Smoking Cessation Market Insights, Share, Growth Drivers and Forecast by 2023

23/gen/2019 13:52:09 P&S Intelligence Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The global smoking cessation market is growing two to growing awareness about health problems associated with smoking and growing acceptance rate of smoking cessation products. On the basis of products, the electronic cigarette segment is expected to grow with the fastest rate during the forecasted period. Nicotine gums led the nicotine replacement therapy market; However, the nicotine lozenges are expected to grow with the fastest rate during the projected period. The innovation of products with improved efficiency is also expected to be an opportunity for growth of the market. The massive unexplored market of smoking cessation in the developing economies is creating abundant growth opportunities for the global market.
Browse report sample at:
Growing number of collaborations and partnerships, growing number of mergers and acquisitions, and growing number of product launches. Tobacco addition can lead to various serious health problems. Smoking cessation is the process of smoking cessation. Nicotine withdrawal symptoms may include feeling hungrier than usual, having trouble thinking, and feeling irritable, anxious and angry. According to the Center for Disease Control and Prevention in 2010, approximately 7 out of every 10 cigarette smokers wanted to quit smoking completely.
Geographically, North America is expected to dominate the global market in the coming years. Asia-Pacific is expected to be the fastest growing region for the market. In addition, the Asia-Pacific market is growing to increase the prevalence of health complications associated with smoking in the emerging countries, such as India and China.
Browse report at:
Johnson & Johnson, GlaxoSmithKline, Njoy Inc., Nicotek LLC, VMR Products LLC, British American Tobacco PLC, Reynolds American Inc., Perrigo, Pfizer, and Novartis.
blog comments powered by Disqus è un servizio offerto da Factotum Srl